CompletedNCT04380610
Improving Scientific Rigor of Renal Clinical Endpoints for Sickle Cell Anemia
Studying Genetic glomerular disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Alabama at Birmingham
- Principal Investigator
- Jeffrey Lebensburger, DO, MSPH, DOUniversity of Alabama at Birmingham
- Intervention
- iohexol GFR(diagnostic_test)
- Enrollment
- 120 enrolled
- Eligibility
- 5-50 years · All sexes
- Timeline
- 2021 – 2025
Study locations (4)
- University of Alabama at Birmingham, Birmingham, Alabama, United States
- University of Illinois Chicage, Chicago, Illinois, United States
- St Jude Childrens Research Hospital, Memphis, Tennessee, United States
- University of Tennessee Health Science Center, Memphis, Tennessee, United States
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04380610 on ClinicalTrials.gov